Mobilization of stem cells by granulocyte colony-stimulating factor for the regeneration of myocardial tissue after myocardial infarction

Publisher Website
Google Scholar
Abstract
Background and objective: Animal data suggest that mobilized bone marrow cells (BMC) may contribute to tissue regeneration after myocardial infarction (MI). However the safety, feasibility and efficacy of treatment with granulocyte colony-stimulating factor (G-CSF) to mobilize BMC after acute myocardial infarction in patients is unknown. We analysed cardiac function and perfusion in 5 patients who were treated with G-CSF in addition to standard therapeutical regimen. Methods and results: 48 h after successful recanalization and stent implantation in 5 patients with acute MI, the patients received 10 mg/kg body weight/day G-CSF subcutaneously for a mean treatment duration of 7.6±0.5 days. Peak value of CD34+ cells, a multipotent subfraction of bone marrow cells, was reached after 5.0±0.7 days. After 3 months of follow-up global left ventricular ejection fraction (determined by radionuclideventriculography) increased significantly from 42.2±6.6 % to 51.6±8.3 % (PConclusion: In patients with acute MI, treatment with G-CSF to mobilize BMC appears to be well toleated under clinical conditions. Improved cardiac function and perfusion may be attributed to BMC-associated promotion of myocardial regeneration and neovascularization.

This publication has 0 references indexed in Scilit: